The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | Who benefits the most from minimally invasive surgery for NSCLC?
Daniel Miller, MD, Medical College of Georgia, Augusta, GA, comments on the importance of choosing the right person for minimally invasive surgery for non-small cell lung cancer (NSCLC). Factors such as age, gender and the forced expiratory volume in 1 second (FEV1) of the patient need to be taken in account for optimal post-surgery outcomes. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
